JCRB1590 TYGBK-8
Cell information
Important Notice(s)On the MTA of this cell line with Kyoto University (for profit organizations in Japan)
Announcement of unavailability of this cell line to overseas researcher outside of Japan
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1590 | Cell Name | TYGBK-8 |
---|---|---|---|
Profile | Human gall bladder cancer cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 38-year-old |
Identity | available | Tissue for Primary Cancer | gallbladder |
Case history | gallbladder cancer (pancreaticobiliary maljunction) | Metastasis | |
Tissue Metastasized | Genetics | p53 mutation exon 7 codon 237 (ATG to ATA?, no K-Ras mutation in codon 12 or 13 | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | moderately differentiated tubular carcinoma, T2N1M1, stage4b |
Classify | tumor | Established by | Shimada, Y. |
Registered by | Shimada, Y. | Regulation for Distribution | |
Comment | Year | 2014 | |
Medium | Ham's F12 medium + RPMI1640 (1 to 1 mix) with 5% fetal calf serum (cultued by collagen coat dish). | Methods for Passages | Cells harvested after treatment with trypsin and EDTA. |
Cell Number on Passage | Race | ||
CO2 Conc. | 5% | Tissue Sampling | gall bladder |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Movies |
---|
LOT Information
Cell No. | JCRB1590 | Cell Name | TYGBK-8 |
---|---|---|---|
LOT No. | 06272014 | Lot Specification | distribution |
Medium | RPMI1640 and Ham's F12 medium (1/1) with 5% heat inactivated fetal bovine serum(SIGMA027K03911)and using BioCoat Collagen 1 100mm Dish(Becton Dickinson #354450 or #356450) | Temperature | 37 C |
Cell Density at Seeding | 1.33-1.58x10^4cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.23x10^6 |
Viability at cell freezing (%) | 97.2 | Antibiotics Used | |
Passage Number | p5* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:12 D13S317:11 D7S820:11,12 D16S539:9 VWA:17,19 TH01:8 AM:X TPOX:8,11 CSF1PO:12 |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |